tilsotolimod,trastuzumab deruxtecan
daiichi sankyo,astrazeneca,idera
['intrim', 'imo-2125', 'melanoma']
 proud of jessica notohardjo presenting results of the intrim study at #esmo22! pre-snb single intradermal injection of imo-2125 vs placebo in pts with pt3-4 #melanoma; 13 vs 45% +sln. pis tanja de gruijl &amp; fons van den eertwegh 
MD PhD, medical oncologist @amsterdamumc
Melanoma • Phase 1 clinical trials •
Precision oncology ?? • 'Moozer' to J & F • ?? ?? ??